CLINICAL_TRIALS
trial_result
· 2019-09-06
Clinical Trial Update: Ebselen as an add-on Treatment in Hypo/Mania [Phase 2]
Summary
Phase 2 clinical trial investigating ebselen as an add-on treatment in bipolar disorder with manic episodes; study completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of Oxford | Conditions: Bipolar Disorder, Bipolar Disorder, Manic | Phase 2 | Status: COMPLETED